Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study
BackgroundAdherence and persistence to positive airway pressure (PAP) therapy are key factors for positive health outcomes. Home support providers participate in the home implementation and follow-up of PAP therapy for patients with obstructive sleep apnea (OSA). In Europe, h...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2025-01-01
|
| Series: | JMIR Research Protocols |
| Online Access: | https://www.researchprotocols.org/2025/1/e65840 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832575623518748672 |
|---|---|
| author | Sarah Alami Manuella Schaller Sylvie Blais Henry Taupin Marta Hernández González Frédéric Gagnadoux Paula Pinto Irene Cano-Pumarega Lieven Bedert Ben Braithwaite Hervé Servy Stéphane Ouary Céline Fabre Fabienne Bazin Joëlle Texereau |
| author_facet | Sarah Alami Manuella Schaller Sylvie Blais Henry Taupin Marta Hernández González Frédéric Gagnadoux Paula Pinto Irene Cano-Pumarega Lieven Bedert Ben Braithwaite Hervé Servy Stéphane Ouary Céline Fabre Fabienne Bazin Joëlle Texereau |
| author_sort | Sarah Alami |
| collection | DOAJ |
| description |
BackgroundAdherence and persistence to positive airway pressure (PAP) therapy are key factors for positive health outcomes. Home support providers participate in the home implementation and follow-up of PAP therapy for patients with obstructive sleep apnea (OSA). In Europe, home support provider service levels are country (or area) specific, resulting in differences in content and frequency of patient interactions. However, no robust evaluation of the impact of these differences on clinical and patient outcomes has been performed.
ObjectiveThe AWAIR study aims to evaluate and compare the impact of different home support provider service levels on PAP adherence and persistence in 4 European countries.
MethodsThis real-world, ambispective, cohort study—conducted in France, Belgium, Spain, and Portugal—will recruit adults with OSA who started PAP therapy between 2019 and 2023 and were followed by an Air Liquide Healthcare home support provider. Given the large number of eligible participants (around 150,000), the study will use a decentralized and digital approach. A patient video will present the study objectives and the participation process. A secure electronic solution will be used to manage patient information and consent, as well as to administer a web-based questionnaire. Retrospective data, collected during routine patient follow-up by home support providers, include the level of service and device data, notably PAP use. Prospective data collected using an electronic patient-reported outcome tool include health status, OSA-related factors, patient-reported outcomes including quality of life and symptoms, OSA and PAP literacy, patient-reported experience, and satisfaction with PAP therapy and service. Hierarchical models, adjusted for preidentified confounding factors, will be used to assess the net effect of home support provider services on PAP adherence and persistence while minimizing real-world study biases and considering the influence of country-level contextual factors. We hypothesize that higher levels of home support provider services will be positively associated with adherence and persistence to PAP therapy.
ResultsAs of December 2024, the study has received approval in France, Portugal, and 2 regions of Spain. The study began enrollment in France in October 2024. Results are expected in the second quarter of 2025.
ConclusionsThe AWAIR study has a unique design, leveraging an unprecedented number of eligible participants, decentralized technologies, and a real-world comparative methodology across multiple countries. This approach will highlight intercountry differences in terms of patient characteristics, PAP adherence, and persistence, as well as patient-reported outcomes, patient-reported experiences, and satisfaction with the home service provider. By assessing the added value of home support provider services, the results will support best practices for patient management and for decision-making by payers and authorities.
International Registered Report Identifier (IRRID)PRR1-10.2196/65840 |
| format | Article |
| id | doaj-art-e28aab5cfe50418686ca5988bd3f8edb |
| institution | Kabale University |
| issn | 1929-0748 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR Research Protocols |
| spelling | doaj-art-e28aab5cfe50418686ca5988bd3f8edb2025-01-31T21:00:35ZengJMIR PublicationsJMIR Research Protocols1929-07482025-01-0114e6584010.2196/65840Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World StudySarah Alamihttps://orcid.org/0000-0001-7893-0011Manuella Schallerhttps://orcid.org/0000-0001-6344-9049Sylvie Blaishttps://orcid.org/0009-0000-6087-8710Henry Taupinhttps://orcid.org/0009-0008-4031-1061Marta Hernández Gonzálezhttps://orcid.org/0009-0005-2984-3428Frédéric Gagnadouxhttps://orcid.org/0000-0002-4231-5102Paula Pintohttps://orcid.org/0000-0003-2301-2752Irene Cano-Pumaregahttps://orcid.org/0000-0003-1543-7187Lieven Bederthttps://orcid.org/0009-0004-7183-1482Ben Braithwaitehttps://orcid.org/0000-0002-7378-1034Hervé Servyhttps://orcid.org/0000-0002-8476-4619Stéphane Ouaryhttps://orcid.org/0009-0001-3447-7099Céline Fabrehttps://orcid.org/0009-0002-2212-6125Fabienne Bazinhttps://orcid.org/0009-0006-4968-3289Joëlle Texereauhttps://orcid.org/0000-0003-4079-2551 BackgroundAdherence and persistence to positive airway pressure (PAP) therapy are key factors for positive health outcomes. Home support providers participate in the home implementation and follow-up of PAP therapy for patients with obstructive sleep apnea (OSA). In Europe, home support provider service levels are country (or area) specific, resulting in differences in content and frequency of patient interactions. However, no robust evaluation of the impact of these differences on clinical and patient outcomes has been performed. ObjectiveThe AWAIR study aims to evaluate and compare the impact of different home support provider service levels on PAP adherence and persistence in 4 European countries. MethodsThis real-world, ambispective, cohort study—conducted in France, Belgium, Spain, and Portugal—will recruit adults with OSA who started PAP therapy between 2019 and 2023 and were followed by an Air Liquide Healthcare home support provider. Given the large number of eligible participants (around 150,000), the study will use a decentralized and digital approach. A patient video will present the study objectives and the participation process. A secure electronic solution will be used to manage patient information and consent, as well as to administer a web-based questionnaire. Retrospective data, collected during routine patient follow-up by home support providers, include the level of service and device data, notably PAP use. Prospective data collected using an electronic patient-reported outcome tool include health status, OSA-related factors, patient-reported outcomes including quality of life and symptoms, OSA and PAP literacy, patient-reported experience, and satisfaction with PAP therapy and service. Hierarchical models, adjusted for preidentified confounding factors, will be used to assess the net effect of home support provider services on PAP adherence and persistence while minimizing real-world study biases and considering the influence of country-level contextual factors. We hypothesize that higher levels of home support provider services will be positively associated with adherence and persistence to PAP therapy. ResultsAs of December 2024, the study has received approval in France, Portugal, and 2 regions of Spain. The study began enrollment in France in October 2024. Results are expected in the second quarter of 2025. ConclusionsThe AWAIR study has a unique design, leveraging an unprecedented number of eligible participants, decentralized technologies, and a real-world comparative methodology across multiple countries. This approach will highlight intercountry differences in terms of patient characteristics, PAP adherence, and persistence, as well as patient-reported outcomes, patient-reported experiences, and satisfaction with the home service provider. By assessing the added value of home support provider services, the results will support best practices for patient management and for decision-making by payers and authorities. International Registered Report Identifier (IRRID)PRR1-10.2196/65840https://www.researchprotocols.org/2025/1/e65840 |
| spellingShingle | Sarah Alami Manuella Schaller Sylvie Blais Henry Taupin Marta Hernández González Frédéric Gagnadoux Paula Pinto Irene Cano-Pumarega Lieven Bedert Ben Braithwaite Hervé Servy Stéphane Ouary Céline Fabre Fabienne Bazin Joëlle Texereau Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study JMIR Research Protocols |
| title | Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study |
| title_full | Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study |
| title_fullStr | Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study |
| title_full_unstemmed | Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study |
| title_short | Evaluating the Benefit of Home Support Provider Services for Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea: Protocol for an Ambispective International Real-World Study |
| title_sort | evaluating the benefit of home support provider services for positive airway pressure therapy in patients with obstructive sleep apnea protocol for an ambispective international real world study |
| url | https://www.researchprotocols.org/2025/1/e65840 |
| work_keys_str_mv | AT sarahalami evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT manuellaschaller evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT sylvieblais evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT henrytaupin evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT martahernandezgonzalez evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT fredericgagnadoux evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT paulapinto evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT irenecanopumarega evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT lievenbedert evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT benbraithwaite evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT herveservy evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT stephaneouary evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT celinefabre evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT fabiennebazin evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy AT joelletexereau evaluatingthebenefitofhomesupportproviderservicesforpositiveairwaypressuretherapyinpatientswithobstructivesleepapneaprotocolforanambispectiveinternationalrealworldstudy |